Plain-English translation of NCT06576752 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new way to care for people who have just been hospitalized for heart failure. Instead of requiring patients to travel to the hospital for weekly visits, this study will have heart failure nurses manage your medications and check on your health from your home using video calls and phone contact. The goal is to make it easier for patients to get the intensive medication adjustments that have been proven to significantly reduce deaths from heart failure.
Many heart failure patients aren't receiving the strongest life-saving medications at the right doses because traveling to the hospital for frequent visits is difficult, especially for people who live far away or have mobility problems. This trial aims to prove that the same intensive, proven treatment can work just as well—or better—when delivered at home, removing a major barrier that keeps patients from getting the care they need.
You likely qualify if…
You likely don't qualify if…
If you are enrolled, you will be randomly assigned to either receive your heart failure follow-up care at home (via video calls with heart failure nurses, with one visit to your primary care doctor around week 2) or at the hospital outpatient clinic. Either way, you will have visits at 1, 2, 3, and 6 weeks after discharge where your heart failure medications will be carefully increased to the best doses, and your health will be closely monitored. The home care group will have the convenience of staying in their home for most visits, while the hospital group will follow the standard approach used in previous successful trials.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Norway